Published in Int J Cardiol on June 02, 1995
von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J (1995) 0.91
Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy. Postgrad Med J (1996) 0.75
Antithrombotic treatment and atrial fibrillation. BMJ (1992) 5.33
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med (2000) 3.90
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J (2002) 2.66
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol (2003) 2.63
Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction. BMJ (1994) 2.46
Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation (2001) 2.43
Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol (1990) 2.43
Treatment of atrial fibrillation in a district general hospital. Br Heart J (1994) 2.40
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation (1996) 2.32
Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J (2000) 2.30
ABC of palliative care. Non-malignant conditions. BMJ (1998) 2.24
Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography. Eur J Echocardiogr (2003) 2.11
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J (1999) 2.08
Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study. Eur Heart J (2000) 2.08
Acute exercise and markers of endothelial injury in peripheral arterial disease. Eur J Vasc Endovasc Surg (1997) 2.07
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia (2011) 2.06
Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med (2008) 2.06
Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction. Eur Heart J (1990) 2.04
Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart (1997) 2.01
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. BMJ (1996) 1.85
Management of paroxysmal atrial fibrillation. Q J Med (1993) 1.75
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J (1988) 1.75
Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol (1997) 1.72
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost (2007) 1.69
Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins. Br J Surg (2010) 1.67
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Direct admission to the coronary care unit by the ambulance service for patients with suspected myocardial infarction. Heart (1997) 1.60
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur Heart J (1993) 1.60
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J (1996) 1.59
Early treatment of myocardial infarction in the community. Br Med J (1978) 1.58
Adrenaline in allergic emergencies. BMJ (1992) 1.53
Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J (1990) 1.49
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia (2004) 1.46
Tissue plasminogen activator inhibition in diabetes mellitus. Diabetes Care (1989) 1.45
Sinus of Valsalva fistula with quadricuspid aortic valve, a first reported association. Int J Cardiol (2005) 1.45
Association of fibrinolytic tests with outcome of acute upper-gastrointestinal-tract bleeding. Lancet (1993) 1.45
Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet (1992) 1.44
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia. J Thromb Haemost (2007) 1.43
Relation between extent of coronary artery disease and blood viscosity. Br Med J (1980) 1.42
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer. Thromb Haemost (1989) 1.39
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Blood rheology in vitro and in vivo. Baillieres Clin Haematol (1987) 1.36
Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J (1993) 1.36
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurements. Clin Chem (1993) 1.35
Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol (1983) 1.34
Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem (2000) 1.34
Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet (1983) 1.34
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol (1996) 1.29
The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scott Med J (1980) 1.28
How periodontal disease may contribute to cardiovascular disease. Periodontol 2000 (2000) 1.26
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J (2004) 1.24
Blood rheology in arterial disease. Clin Sci (Lond) (1986) 1.23
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J (1992) 1.22
Fatal retroperitoneal haemorrhage complicating anticoagulant therapy. Postgrad Med J (1979) 1.21
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet (1990) 1.20
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (1999) 1.17
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol (1997) 1.17
Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost (2009) 1.16
Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Blood Coagul Fibrinolysis (1995) 1.16
Neuroendocrine activation after acute myocardial infarction. Br Heart J (1988) 1.16
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Diagnosis and treatment of venous thromboembolism by consultants in Scotland. Br Med J (Clin Res Ed) (1983) 1.14
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet (1993) 1.14
Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci (Lond) (1995) 1.13
Laboratory diagnosis of congenital coagulation defects. Clin Haematol (1979) 1.13
Changes in neutrophil deformability following in vitro smoke exposure: mechanism and protection. Am J Respir Cell Mol Biol (1992) 1.13
Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate? Br Med J (Clin Res Ed) (1983) 1.12
Blood viscosity as a factor in sensorineural hearing impairment. Lancet (1986) 1.12
Increased platelet aggregates in vascular and nonvascular illness: correlation with plasma fibrinogen and effect of ancrod. Thromb Res (1979) 1.10
Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J (1981) 1.10